4th QUARTER/Full Year 2023
Reporting
Evonik published its quarterly report Q4/FY 2023 on March 4, 2024.
You can access further information here.
- Q4 adj. EBITDA of €312 m to finish the year at €1,656 m and within outlook range (€1.6 to 1.8 bn) despite around -€50 m exceptional headwinds in Q4
- Update on reorganization program “Evonik Tailor Made”: Total savings of €400 m targeted by end of 2026
- FCF of €801 m stable yoy despite significant earnings decline, covering attractive & stable dividend proposal of €1.17
- FY 2024 adj. EBITDA outlook of €1.7 to 2.0 bn: Earnings growth enabled by cost savings and Animal Nutrition; Q1 already expected above prior-year level
Reporting 4th Quarter/FY 2023
|
Document
|
Link / PDF
|
|
Analyst & Investor Factsheet
|
|
|
Presentation Conference Call
|
|
|
Detailed overview of key financial data (Evonik Financials) - PDF |
|
|
Detailed overview of key financial data (Evonik Financials) - Excel |
|
|
Detailed overview of ESG data - PDF |
|
|
Detailed overview of ESG data - Excel |
|
|
Financial Report 2023 |
|
|
Sustainability Report 2023 |
|
|
Investor Relations News Q4/FY 2023 |
|
|
Analysts' consensus* (Vara Research)
|
|
|
Webcast Conference Call Q4/FY 2023 |
* The consensus is not controlled, changed or censored by Evonik Industries AG. Evonik Industries AG assumes no liability for the accuracy and completeness of these estimates and undertakes no obligation to update or revise such estimates and consensus data, even if they differ from Evonik Industries AG’s own forecasts or expectations. Evonik Industries AG is neither involved in the collection of the data, nor in the preparation of the consensus. This is done independently by Vara Research.